Startups
Velocity Pharmaceutical Development (VPD) was formed by CMEA Capital to make majority ownership, controlling purchases of drug candidates and to develop these candidates using a cost-efficient “build to sell” model. VPD’s strategy is to create, invest in, and manage a portfolio of “project-focused companies,” each of which contains a single drug candidate acquired from a third party. VPD designs and executes the clinical development program for each of these drug candidates.
Overview
Location
United States, California, South San Francisco
Phone
+1 650-745-8179
Founded date
2011
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 21, 2013 | Pharma licensing deal yields virtual startup that’s optimizing peptide drugs, raising $9.5M | “The EuMederis model of rapid peptide optimization has quickly provided us with an attractive peptide development candidate and its low-infrastructure organization is consistent with our plan for Velocity Pharmaceutical Development,” Veloci... |
| Bristol-Myers Squibb files a lawsuit against former oncology executive, Baxter’s venture arm and Mayo Clinic launch biotech co. (Morning Read) | TOP STORIES The venture arm of Baxter International formed a biotech collaboration with Mayo Clinic and Velocity Pharmaceutical Development to develop treatments for cancer and other diseases. Vitesse Biologics will search for new therapeut... | |
| Pharma licensing deal yields virtual startup that’s optimizing peptide drugs, raising $9.5M | A licensing deal between two California pharmaceutical companies has resulted in the formation of a new San Francisco startup developing an unspecified peptide drug candidate. With the creation of the virtual company Spitfire Pharma Inc., V... |
Reviews 0
FAQ about Velocity Pharmaceutical Development, LLC
When was Velocity Pharmaceutical Development, LLC founded?
Velocity Pharmaceutical Development, LLC was founded in 2011.
What has the press written about Velocity Pharmaceutical Development, LLC?
Parsers VC has collected 4 articles mentioning Velocity Pharmaceutical Development, LLC, among them “Pharma licensing deal yields virtual startup that’s optimizing peptide drugs, raising $9.5M” (Jan 21, 2013) and “Bristol-Myers Squibb files a lawsuit against former oncology executive, Baxter’s venture arm and Mayo Clinic launch biotech co. (Morning Read)”.
Is Velocity Pharmaceutical Development, LLC still active?
Yes, Velocity Pharmaceutical Development, LLC is active; its latest activity on Parsers VC dates from Jun 2, 2015.